Deborah Sims
CLL Patient
Deborah Sims is a young chronic lymphocytic leukaemia (CLL) patient living in Australia and mother of three children. She participated in a clinical trial of obinutuzumab and venetoclax (ABT-199) in Barts Cancer Institute (London) and five years after her diagnose she is in remission.
